Kali Inc KALY:Over The Counter Market

Last Price$0.0000Over The Counter Market Previous Close - Last Trade as of 9:30AM ET 8/01/22
Over The Counter Market 15-minute delayed Bid/Ask Quotes
Today's Change0(0.00%)
Bid (Size)$0.0001 (10,000)
Ask (Size)$0.0003 (10,000)
Day Low / HighN/A - N/A
Volume1.2 K
 

View Apparel/Footwear IndustryPeer Comparison as of 08/01/2022

 

Kali Inc ( OTC )

Price: $0.00
Change: 0.00 (0.00%)
Volume: 1.2 K
9:30AM ET 8/01/2022
 
 

Vitamin Blue Inc ( OTC )

Price: $0.0001
Change: 0.00 (0.00%)
Volume: 100.0 K
9:30AM ET 7/27/2022
 
 

Lot78 Inc ( OTC )

Price: $0.0011
Change: 0.00 (0.00%)
Volume: 133.0 K
3:30PM ET 8/10/2022
 
 

Star Nutrition Inc ( OTC )

Price: $0.02
Change: 0.00 (0.00%)
Volume: 2.00
9:30AM ET 9/03/2021
 
 

Mondial Ventures Inc ( OTC )

Price: $0.00
Change: 0.00 (0.00%)
Volume: 50.0 K
9:54AM ET 7/29/2022
 

Read more news Recent News

No news stories available at this time.

View all Commentary and Analysis

No news stories available at this time.

Company Profile

Business DescriptionKali, Inc. engages in the development of pharmaceuticals to treat illnesses, diseases, and chronic pain. It also focuses on research of health and wellness therapies. The company was founded by Bradley W. Miller on October 30, 2006 and is headquartered in Dallas, TX. View company web site for more details
Address8300 Douglas Avenue
Dallas, Texas 75225
Phone+1.214.210.0459
Number of EmployeesN/A
Chief Executive OfficerFrederick Ferri

Company Highlights

Price Open$0.00
Previous Close$0.00
52 Week Range$0.00 - 0.0004
Market Capitalization$1.5 K
Shares Outstanding1.5 B
SectorConsumer Non-Durables
IndustryApparel/Footwear
Next Earnings AnnouncementN/A

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$0.00
Beta vs. S&P 500N/A
Revenue$65.3 K
Net Profit Margin-18.24%
Return on Equity4.70%